Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Obesity
|
1111 | 0.554 | 0.760 | 1 | 65592830 | missense variant | A/G | snv | 0.51 | 0.50 | 0.100 | 0.903 | 31 | 2001 | 2018 | ||||
Breast Carcinoma
|
2793 | 0.554 | 0.760 | 1 | 65592830 | missense variant | A/G | snv | 0.51 | 0.50 | 0.080 | 0.750 | 8 | 2008 | 2017 | ||||
Malignant neoplasm of breast
|
3417 | 0.554 | 0.760 | 1 | 65592830 | missense variant | A/G | snv | 0.51 | 0.50 | 0.080 | 0.750 | 8 | 2008 | 2017 | ||||
Metabolic Syndrome X
|
591 | 0.554 | 0.760 | 1 | 65592830 | missense variant | A/G | snv | 0.51 | 0.50 | 0.060 | 1.000 | 6 | 2009 | 2018 | ||||
Sleep Apnea, Obstructive
|
105 | 0.554 | 0.760 | 1 | 65592830 | missense variant | A/G | snv | 0.51 | 0.50 | 0.060 | 1.000 | 6 | 2007 | 2019 | ||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.554 | 0.760 | 1 | 65592830 | missense variant | A/G | snv | 0.51 | 0.50 | 0.040 | 0.750 | 4 | 2005 | 2018 | ||||
Hypertensive disease
|
1085 | 0.554 | 0.760 | 1 | 65592830 | missense variant | A/G | snv | 0.51 | 0.50 | 0.040 | 0.750 | 4 | 2012 | 2018 | ||||
Malignant Neoplasms
|
1641 | 0.554 | 0.760 | 1 | 65592830 | missense variant | A/G | snv | 0.51 | 0.50 | 0.040 | 0.250 | 4 | 2012 | 2019 | ||||
Polycystic Ovary Syndrome
|
363 | 0.554 | 0.760 | 1 | 65592830 | missense variant | A/G | snv | 0.51 | 0.50 | 0.040 | 0.750 | 4 | 2013 | 2019 | ||||
Primary malignant neoplasm
|
1374 | 0.554 | 0.760 | 1 | 65592830 | missense variant | A/G | snv | 0.51 | 0.50 | 0.040 | 0.250 | 4 | 2012 | 2019 | ||||
Non-alcoholic Fatty Liver Disease
|
222 | 0.554 | 0.760 | 1 | 65592830 | missense variant | A/G | snv | 0.51 | 0.50 | 0.030 | 1.000 | 3 | 2013 | 2018 | ||||
Cardiovascular Diseases
|
711 | 0.554 | 0.760 | 1 | 65592830 | missense variant | A/G | snv | 0.51 | 0.50 | 0.020 | 1.000 | 2 | 2014 | 2017 | ||||
Childhood Acute Lymphoblastic Leukemia
|
261 | 0.554 | 0.760 | 1 | 65592830 | missense variant | A/G | snv | 0.51 | 0.50 | 0.020 | 0.500 | 2 | 2004 | 2011 | ||||
Conventional (Clear Cell) Renal Cell Carcinoma
|
222 | 0.554 | 0.760 | 1 | 65592830 | missense variant | A/G | snv | 0.51 | 0.50 | 0.020 | 1.000 | 2 | 2014 | 2018 | ||||
Coronary Artery Disease
|
1577 | 0.554 | 0.760 | 1 | 65592830 | missense variant | A/G | snv | 0.51 | 0.50 | 0.020 | 1.000 | 2 | 2018 | 2019 | ||||
Dyslipidemias
|
184 | 0.554 | 0.760 | 1 | 65592830 | missense variant | A/G | snv | 0.51 | 0.50 | 0.020 | 1.000 | 2 | 2010 | 2015 | ||||
Impaired glucose tolerance
|
81 | 0.554 | 0.760 | 1 | 65592830 | missense variant | A/G | snv | 0.51 | 0.50 | 0.020 | 1.000 | 2 | 2001 | 2005 | ||||
Lip and Oral Cavity Carcinoma
|
172 | 0.554 | 0.760 | 1 | 65592830 | missense variant | A/G | snv | 0.51 | 0.50 | 0.020 | 0.500 | 2 | 2009 | 2019 | ||||
Malignant neoplasm of mouth
|
184 | 0.554 | 0.760 | 1 | 65592830 | missense variant | A/G | snv | 0.51 | 0.50 | 0.020 | 0.500 | 2 | 2009 | 2019 | ||||
Malignant neoplasm of prostate
|
1082 | 0.554 | 0.760 | 1 | 65592830 | missense variant | A/G | snv | 0.51 | 0.50 | 0.020 | 1.000 | 2 | 2003 | 2016 | ||||
Neoplasms
|
1644 | 0.554 | 0.760 | 1 | 65592830 | missense variant | A/G | snv | 0.51 | 0.50 | 0.020 | 1.000 | 2 | 2015 | 2018 | ||||
Overweight and obesity
|
29 | 0.554 | 0.760 | 1 | 65592830 | missense variant | A/G | snv | 0.51 | 0.50 | 0.020 | 1.000 | 2 | 2016 | 2018 | ||||
Pediatric Obesity
|
67 | 0.554 | 0.760 | 1 | 65592830 | missense variant | A/G | snv | 0.51 | 0.50 | 0.020 | 1.000 | 2 | 2018 | 2018 | ||||
Prostate carcinoma
|
1168 | 0.554 | 0.760 | 1 | 65592830 | missense variant | A/G | snv | 0.51 | 0.50 | 0.020 | 1.000 | 2 | 2003 | 2016 | ||||
Psychotic Disorders
|
179 | 0.554 | 0.760 | 1 | 65592830 | missense variant | A/G | snv | 0.51 | 0.50 | 0.020 | 1.000 | 2 | 2011 | 2019 |